Up‐modulation of interferon‐γ mediates the enhancement of spontanous cytotoxicity in prolactin‐activated natural killer cells

Immunology - Tập 98 Số 3 - Trang 386-392 - 1999
Lina Matera1, M. Contarini, Graziella Bellone, B Forno, A Biglino
1Department of Internal Medicine, University of Turin, Italy

Tóm tắt

SummaryProlactin (PRL) has been shown to participate in lymphocyte activation. In particular, the constitutive natural killer (NK) and the lymphokine‐activated killer (LAK) cytotoxicity of CD56+ CD16+ cells is increased by its physiological to supraphysiological concentrations. As PRL has been shown to up‐regulate the production of interferon‐γ (IFN‐γ) by peripheral blood mononuclear cells, we studied its effect on IFN‐γ production by NK cells as a possible mechanism of autocrine activation of cytotoxicity. Released and intracellular IFN‐γ, as well as IFN‐γ mRNA expression, were increased by pituitary and recombinant human PRL, which stimulated optimal NK and LAK cytotoxicity. Treatment with blocking anti‐IFN‐γ monoclonal antibody (mAb) selectively affected PRL‐increased killing of K562 targets, demonstrating that PRL‐mediated enhancement of spontaneous cytotoxicity depends, at least in part, on up‐regulation of IFN‐γ.

Từ khóa


Tài liệu tham khảo

10.1073/pnas.89.16.7713

Hartman D.P., 1989, Inhibition of lymphocyte proliferation by antibodies to prolactin., FASEB J, 3, 2194, 10.1096/fasebj.3.10.2787766

10.3181/00379727-198-43286B

10.1016/S0065-2776(08)60860-3

10.1016/0024-3205(96)00225-1

10.1046/j.1365-2567.1996.d01-773.x

10.1016/0162-3109(94)90040-X

10.1016/0889-1591(92)90039-Q

10.3181/00379727-213-44051

10.1016/0092-8674(90)90182-E

O'Neal K.D., 1993, The proline‐rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily., Lymph Cyt Res, 12, 309

10.3181/00379727-215-44111

10.1677/joe.0.1570187

10.1084/jem.184.5.2043

10.1016/S0065-2776(08)60664-1

10.1016/0952-7915(91)90076-D

10.1007/BF00915477

10.1016/0162-3109(87)90004-X

10.1002/(SICI)1097-0215(19960328)66:1<65::AID-IJC12>3.0.CO;2-A

10.1146/annurev.bb.22.060193.001553

Russell D.H., 1985, Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporin., J Immunol, 134, 3027, 10.4049/jimmunol.134.5.3027

10.1016/0889-1591(88)90001-3

10.3181/00379727-205-43683

10.1146/annurev.immunol.16.1.359

10.1007/978-3-642-46859-9_2

10.1016/S0952-7915(98)80163-5

Cosman D., 1997, Interleukin 15., Biochem Soc Trans, 25, 371, 10.1042/bst0250371

10.1084/jem.188.11.2067

Berczi I., 1993, Prolactin, pregnancy and autoimmune disease. J., Rheumatol, 20, 1095

10.1016/1043-2760(93)90103-L

Mok C.C., 1998, Hyperprolactinemia in males with systemic lupus erythematosus., J Rheumatol, 25, 2357

10.1210/jc.82.11.3664

10.1093/rheumatology/32.6.445

10.1002/ana.410290514

10.1006/clin.1996.0118

10.1210/endo-125-6-2853

Ramirez F., 1996, Glucorticoids promote a Th2 cytokine response by CD4+ T cells in vitro., J Immunol, 156, 2406, 10.4049/jimmunol.156.7.2406

10.1016/S0264-410X(98)80106-0

10.3109/00207459008999716